Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Endocrine-Related Cancer|January 31, 2014
Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapiesJosé O Alemán, Azeez Farooki, Monica GirotraTreatments in Endocrinology|November 17, 2006
Anabolic Agents for Osteoporosis : What is Their Likely Place in Therapy?Monica Girotra, Mishaela R Rubin, John P BilezikianReviews in Endocrine & Metabolic Disorders|October 18, 2006
The use of parathyroid hormone in the treatment of osteoporosisMonica Girotra, Mishaela R Rubin, John P BilezikianArquivos Brasileiros De Endocrinologia E Metabologia|November 23, 2006
Anabolic skeletal therapy for osteoporosisMonica Girotra, Mishaela R Rubin, John P BilezikianAnnals of Internal Medicine|May 19, 2010
Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancerKouta Ito, Elena B Elkin, Monica Girotra, et al.British Journal of Anaesthesia|February 3, 2020
Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologistAlexandra L Lewis, Jamie Chaft, Monica Girotra, et al.Nature Reviews. Endocrinology|January 21, 2017
Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathiesDavid J Byun, Jedd D Wolchok, Lynne M Rosenberg, et al.The Oncologist|December 1, 2019
Extended Survival After Surgical Resection for Pituitary Metastases: Clinical Features, Management, and Outcomes of Metastatic Disease to the SellaKrupa R Patel, Junting Zheng, Viviane Tabar, et al.Diabetes Care|October 14, 2020
Immune Checkpoint Inhibitor-Associated Diabetes: A Single-Institution ExperienceDavid J Byun, Rebecca Braunstein, Jessica Flynn, et al.Metabolism: Clinical and Experimental|April 15, 2011
Leptin administration does not prevent the bone mineral metabolism changes induced by weight lossRushika Conroy, Monica Girotra, Elizabeth Shane, et al.Pageof 3